To classify the types of diabetic macular edema (DME) and evaluate its morphological features on spectral domain optical coherence tomography (SD-OCT) and determine correlations between visual acuity and OCT findings.
We assessed 406 eyes of 309 patients with a diagnosis of DME retrospectively. Three types based on SD-OCT were identified: diffuse macular edema, cystoid macular edema, and cystoid degeneration. Morphological features such as serous macular detachment (SMD), vitreomacular interface abnormalities (VMAI), hard exudates, photoreceptor status, and correlations between visual acuity and those morphological features were also evaluated by SD-OCT.
The most common type of DME was cystoid edema (68.5%). No statistically significant difference was found between groups in sex (P = 0.40), type of diabetes (P = 0.50), or diabetic retinopathy (P = 0.78). However, the duration of symptoms and BCVA was significantly lower in the group with cystoid degeneration compared with the group with cystoid edema (P < 0.001) and the group with diffuse macular edema (P < 0.001). In the group with cystoid degeneration compared with the groups with cystoid and diffuse edema, the central fovea and central subfield were significantly thicker (both (P < 0.001), the subfoveal choroid was significantly thinner (P = 0.049), rate of serous macular detachment was significantly lower (P < 0.001), and the rate of outer retinal damage was significantly higher (P < 0.001).
Cystoid macular degeneration, which is consistent with poor functional and morphological outcomes, should be differentiated from cystoid macular edema. Serous macular detachment, which is mostly seen in eyes with early stages of DME, should be evaluated as an accompanying morphological finding rather than a type of DME.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Lee R, Wong TY, Sabanayagam C (2015) Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond) 2:17
Schmidt-Erfurth U, Garcia-Arumi J, Bandello F et al (2017) Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica 237(4):185–222
Bandello F, Battaglia Parodi M, Lanzetta P et al (2010) Diabetic macular edema. Dev Ophthalmol 47:73–110
Yanoff M, Fine BS, Brucker AJ et al (1984) Pathology of human cystoid macular edema. Surv Ophthalmol 28:505–511
Ozdemir H, Karacorlu M, Karacorlu S (2005) Serous macular detachment in diabetic cystoid macular edema. Acta Ophthalmol Scand 83(1):63–66
Vujosevic S, Torresin T, Berton M et al (2017) Diabetic macular edema with and without subfoveal neuroretinal detachment: two different morphologic and functional entities. Am J Ophthalmol 181:149–155
Kim BY, Smith SD, Kaiser PK (2006) Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol 142:405–412
Otani T, Kishi S, Maruyama Y (1999) Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 127:688–693
Muslubas IS, Ersoz MG, Hocaoglu M et al (2018) Morphological and functional changes immediately after half-time photodynamic therapy in patients with central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina 49(12):932–940
Murakami T, Nishijima K, Sakamoto A et al (2011) Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy. Am J Ophthalmol 151:310–317
Gaucher D, Sebah C, Erginay A et al (2008) Optical coherence tomography features during the evaluation of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol 145(2):289–296
Duker JS, Kaiser PK, Binder S et al (2013) The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120:2611–2619
Otani T, Kishi S (2001) Tomographic findings of foveal hard exudates in diabetic macular edema. Am J Ophthalmol 131:50–54
Ruia S, Saxena S, Cheung CMG et al (2016) Spectral domain optical coherence tomography features and classification systems for diabetic macular edema: a review. Asia Pac J Ophthalmol 5:360–367
Panozzo G, Parolini B, Gusson E et al (2004) Diabetic macular edema: an OCT-based classification. Semin Ophthalmol 19:13–20
Pannicke T, Iandiev I, Uckermann O et al (2004) A potassium channel-linked mechanism of glial cell swelling in the postischemic retina. Mol Cell Neurosci 26(4):493–502
Coughlin BA, Feenstra DJ, Mohr S (2017) Müller cells and diabetic retinopathy. Vis Res 139:93–100
Murakami T, Nishijima K, Sakamoto A et al (2011) Foveal cystoid spaces are associated with enlarged foveal avascular zone and microaneurysms in diabetic macular edema. Ophthalmology 118:359–367
Koleva-Georgieva DN, Sinkova NP (2008) Types of diabetic macular edema assessed by optical coherence tomography. Folia Med 50:30–38
Campos A, Campos EJ, Martins J et al (2017) Viewing the choroid: where we stand, challenges and contradictions in diabetic retinopathy and diabetic macular oedema. Acta Ophthalmol 95(5):446–459
Bolz M, Schmidth-Erfurth U, Deak G et al (2009) Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 116(5):914–920
Davoudi S, Papavasileiou E, Roohipoor R et al (2016) Optical coherence tomography characteristics of macular edema and hard exudates and their association with lipid serum levels in type 2 diabetes. Retina 36(9):1622–1629
Ota M, Nishijima K, Sakamoto A et al (2010) Optical coherence tomographic evaluation of foveal hard exudates in patients with diabetic maculopathy accompanying macular detachment. Ophthalmology 117(10):1996–2002
Ophir A, Martinez MR, Mosqueda P et al (2010) Vitreous traction and epiretinal membranes in diabetic macular oedema using spectral-domain optical coherence tomography. Eye 24:1545–1553
Mikhail M, Stewart S, Seow F et al (2018) Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy. Graefes Arch Clin Exp Ophthalmol 256(8):1411–1418
Jain A, Saxena S, Khanna VK et al (2013) Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus. Mol Vis 19:1760–1768
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent licensing arrangements), or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (name the institution/committee) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. “For this type of study formal consent is not required.”
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Arf, S., Sayman Muslubas, I., Hocaoglu, M. et al. Spectral domain optical coherence tomography classification of diabetic macular edema: a new proposal to clinical practice. Graefes Arch Clin Exp Ophthalmol 258, 1165–1172 (2020). https://doi.org/10.1007/s00417-020-04640-9
- Diabetic macular edema
- Serous macular detachment
- Cystoid macular edema
- Diffuse macular edema
- Cystoid macular degeneration